BioSpace News Archive

Allogene Therapeutics, Inc. today announced the appointment of David M. Tillett, Ph.D., as Senior Vice President, Head of Quality.

Medicenna Therapeutics Corp. a clinical stage immuno-oncology company, is pleased to announce that preclinical data on its IL-2 Superkine, MDNA109

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection

Neurotrope has also been selected to present at the 25th Annual NewsMakers in the Biotech Industry on September 7th, 2018

Community Senior Services (CSS), a nonprofit community service organization, announces that it has now provided more than 250,000 trips and two million miles of volunteer transportation for senior and disabled residents who live in sixteen Southern California

A live webcast of the presentation for each of these conferences, excluding the BioCentury NewsMakers lunch panel discussion, will be available on the Investors/Media section of Infinity’s website

Tenax Therapeutics , Inc. (NASDAQ: TENX) today announced the results of a new study titled “Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment: A Randomized Double‐Blind Controlled Trial” were published in the August 21, 2018 issue of the Journal of the American Heart Association (

(BUSINESS WIRE)-- Medidata (NASDAQ: MDSO) today announced its participation in two upcoming investor conferences.

Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today that it has entered into amendments with The University of Texas MD Anderson Cancer Center (MD Anderson) to extend the terms of two option agreements between Genprex and MD Anderson

Nevada Recovery PAC will launch a platform for candidates and recovery supporters on Wednesday August 29, 2018.